vimarsana.com
Home
Live Updates
Astellas Receives Permanent J-code for IZERVAY™ (avac
Astellas Receives Permanent J-code for IZERVAY™ (avac
Astellas Receives Permanent J-code for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy
Permanent J-code J2782 effective April 1, 2024
NORTHBROOK, Ill., March 26, 2024 /PRNewswire/ -- Iveric Bio, An Astellas Company , today announced the U.S. Centers for Medicare and Medicaid Services...
Related Keywords
Naoki Okamura ,
Michael Petroutsas ,
Iveric Bio ,
Medicaid Services ,
Astellas Pharma Inc ,
Astellas Company ,
Astellas Pharma Us Inc ,
Us Centers For Medicare ,
Healthcare Common Procedure Coding System ,
Focus Area Approach ,
Markets ,